CELUW
Income statement / Annual
Last year (2023), Celularity Inc.'s total revenue was $22.77 M,
an increase of 26.68% from the previous year.
In 2023, Celularity Inc.'s net income was -$196.30 M.
See Celularity Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
Operating Revenue |
$22.77 M
|
$17.98 M
|
$21.34 M
|
$14.28 M
|
$21.15 M
|
$17.55 M
|
Cost of Revenue |
$16.02 M |
$19.67 M |
$9.65 M |
$4.93 M |
$6.32 M |
$6.56 M |
Gross Profit |
$6.76 M |
-$1.69 M |
$11.68 M |
$9.35 M |
$14.82 M |
$11.00 M |
Gross Profit Ratio |
0.3 |
-0.09 |
0.55 |
0.65 |
0.7 |
0.63 |
Research and Development
Expenses |
$30.47 M
|
$78.36 M
|
$88.35 M
|
$52.71 M
|
$46.05 M
|
$29.06 M
|
General & Administrative
Expenses |
$50.53 M
|
$65.86 M
|
$71.09 M
|
$30.57 M
|
$564,339.00
|
$0.00
|
Selling & Marketing
Expenses |
$44,000.00
|
$163,000.00
|
$252,000.00
|
$764,000.00
|
$1.16 M
|
$0.00
|
Selling, General &
Administrative Expenses |
$50.58 M
|
$66.02 M
|
$71.34 M
|
$31.34 M
|
$1.68 M
|
$1,098.00
|
Other Expenses |
$118.00 M |
$2.19 M |
$50.75 M |
$3.39 M |
$0.00 |
$0.00 |
Operating Expenses |
$215.06 M |
$146.58 M |
$159.69 M |
$87.44 M |
$1.68 M |
$1,098.00 |
Cost And Expenses |
$215.06 M |
$166.24 M |
$169.35 M |
$92.37 M |
$1.68 M |
$1,098.00 |
Interest Income |
$320,000.00 |
$365,000.00 |
$332,000.00 |
$370,000.00 |
$694,000.00 |
$628,000.00 |
Interest Expense |
$3.02 M |
$0.00 |
$3.17 M |
$2.35 M |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$9.32 M
|
$9.38 M
|
$8.82 M
|
$8.17 M
|
$6.19 M
|
$4.79 M
|
EBITDA |
-$183.95 M
|
$23.58 M
|
-$88.11 M
|
-$202.41 M
|
-$1.68 M
|
-$1,098.00
|
EBITDA Ratio |
-8.08 |
-7.85 |
-4.54 |
-4.58 |
-0.08 |
-0 |
Operating Income Ratio
|
-8.44
|
-1.42
|
-6.94
|
-5.47
|
-0.08
|
-0
|
Total Other
Income/Expenses Net |
-$4.00 M
|
$39.81 M
|
$8.96 M
|
-$61.01 M
|
$7.11 M
|
$2.00
|
Income Before Tax |
-$196.29 M |
$14.21 M |
-$100.10 M |
-$212.93 M |
$6.55 M |
-$1,098.00 |
Income Before Tax Ratio
|
-8.62
|
0.79
|
-4.69
|
-14.91
|
0.31
|
-0
|
Income Tax Expense |
$10,000.00 |
$13,000.00 |
$20,000.00 |
-$4.70 M |
$668,230.00 |
$21.30 M |
Net Income |
-$196.30 M |
$14.19 M |
-$100.12 M |
-$208.23 M |
$5.88 M |
-$1,098.00 |
Net Income Ratio |
-8.62 |
0.79 |
-4.69 |
-14.58 |
0.28 |
-0 |
EPS |
-11.02 |
1.01 |
-8.04 |
-22.67 |
2.46 |
0 |
EPS Diluted |
-11.02 |
0.9 |
-8.08 |
-22.67 |
2.46 |
0 |
Weighted Average Shares
Out |
$17.81 M
|
$15.77 M
|
$12.45 M
|
$9.19 M
|
$2.39 M
|
$35.94 M
|
Weighted Average Shares
Out Diluted |
$17.81 M
|
$14.98 M
|
$12.39 M
|
$9.19 M
|
$2.39 M
|
$35.94 M
|
Link |
|
|
|
|
|
|